anti-C-MYC (MYC) Antikörper

Bezeichnung:
anti-V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) Antikörper (MYC)
Auf www.antikoerper-online.de finden Sie aktuell 696 V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Antikörper von 32 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen C-MYC Kits (47) und C-MYC Proteine (27) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 799 C-MYC Produkte verfügbar.
Synonyme:
AU016757, bHLHe39, C-MYC, CMyc, LOC100136746, mMyc, MRTL, MYC, Myc2, MYCC, Niard, Nird, RNCMYC, zc-myc
Alle Antikörper anzeigen Gen GeneID UniProt
Anti-Ratte MYC MYC 24577 P09416
MYC 17869 P01108
MYC 4609 P01106

Alle Spezies anzeigen

Weitere Synonyme anzeigen

Alle verfügbaren anti-C-MYC Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-C-MYC Antikörper

  1. Human Polyclonal C-MYC Primary Antibody für EIA, WB - ABIN358293 : Qi, Gregory, Li, Brousal, West, Hann: p19ARF directly and differentially controls the functions of c-Myc independently of p53. in Nature 2004 (PubMed)
    Zeige alle 5 Referenzen für 358293

  2. Human Monoclonal C-MYC Primary Antibody für IF, IHC (p) - ABIN1105578 : Liao, Thakur, Wu, Biliran, Sarkar: Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. in Critical reviews in oncogenesis 2008 (PubMed)
    Zeige alle 4 Referenzen für 1105578

  3. Human Polyclonal C-MYC Primary Antibody für EIA, WB - ABIN4620435 : Lima, Bousquet, Gomez-Brouchet, de Paiva, Amstalden, Soares, Dastugue, Vassallo, Brousset: Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene. in American journal of clinical pathology 2008 (PubMed)
    Zeige alle 3 Referenzen für 4620435

  4. Human Polyclonal C-MYC Primary Antibody für EIA, WB - ABIN4620436 : Ida, Ogata, Okumura, Taguchi: Changes in the gene expression of C-myc and CD38 in HL-60 cells during differentiation induced by nicotinic acid-related compounds. in Bioscience, biotechnology, and biochemistry 2008 (PubMed)
    Zeige alle 3 Referenzen für 4620436

  5. Human Polyclonal C-MYC Primary Antibody für EIA, IHC (p) - ABIN4620434 : Iijima, Teraoka, Date, Tsukada: DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein. in European journal of biochemistry / FEBS 1992 (PubMed)
    Zeige alle 3 Referenzen für 4620434

  6. Human Monoclonal C-MYC Primary Antibody für EIA, FACS - ABIN119684 : Spandidos, Pintzas, Kakkanas, Yiagnisis, Mahera, Patra, Agnantis: Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. in Anticancer research 1988 (PubMed)
    Zeige alle 2 Referenzen für 119684

  7. Human Monoclonal C-MYC Primary Antibody für FACS, IHC (fro) - ABIN119682 : Evan, Lewis, Ramsay, Bishop: Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. in Molecular and cellular biology 1986 (PubMed)
    Zeige alle 2 Referenzen für 119682

  8. Mammalian Monoclonal C-MYC Primary Antibody für IF, IP - ABIN1105582 : Watanabe, Honma, Furusawa, Sakurai, Sato: Preparation of enzymatically active human Myc-tagged-NCre recombinase exhibiting immunoreactivity with anti-Myc antibody. in Molecular reproduction and development 2006 (PubMed)

  9. Human Polyclonal C-MYC Primary Antibody für WB - ABIN2668789 : Kohn, Yang, Du, Nagano, Van Schyndle, Herrmann, Heldman, Chen, Stuelten, Flanders, Wakefield: Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. in Molecular cancer research : MCR 2012 (PubMed)

Weitere Antikörper gegen C-MYC Interaktionspartner

Mouse (Murine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Interaktionspartner

  1. Data, including data from studies in cells from knockout mice, suggest that Prmt1 (zeige PRMT1 Antikörper) activity was necessary for c-Myc binding to acetyltransferase p300 (zeige NOTCH1 Antikörper) in myeloid cells; Prmt1 (zeige PRMT1 Antikörper) inhibition decreases p300 (zeige NOTCH1 Antikörper) recruitment to c-Myc target promoters and increased Hdac1 (zeige HDAC1 Antikörper) recruitment. [Prmt1 (zeige PRMT1 Antikörper), protein arginine N-methyltransferase 1 (zeige PRMT1 Antikörper); c-Myc = Proto-Oncogene (zeige RAB1A Antikörper) Proteins c-myc; Hdac1 (zeige HDAC1 Antikörper) = histone deacetylase 1 (zeige HDAC1 Antikörper)]

  2. MYC-dependent attenuation of GCLC (zeige GCLC Antikörper) by miR (zeige MLXIP Antikörper)-18a contributes to GSH depletion in vivo, and low GSH corresponds with increased sensitivity to oxidative stress in tumors.

  3. MYC mediates cell cycle re-entry of Trp53 (zeige TP53 Antikörper)-altered hepatocytes via AURKA (zeige AURKA Antikörper) binding.

  4. Modification of the tumor microenvironment in KRAS or c-MYC-induced ovarian cancer-associated peritonitis has been described.

  5. Myc can substitute for Notch1 (zeige NOTCH1 Antikörper) in leukemogenesis

  6. interplay between MATalpha1, c-Myc, and Maf (zeige MAF Antikörper) proteins, and their deregulation during chronic cholestasis may facilitate cholangiocarcinoma oncogenesis

  7. our results show how MYC drives the production of specific eicosanoids critical for lung cancer cell survival and proliferation

  8. Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf (zeige BMF Antikörper) expression

  9. Data (including data from studies using transgenic mice) suggest that expression of c-Myc in liver can be correlated with progression, regression, and recurrence of hepatocellular carcinoma (using a specific mouse model).

  10. TCF7L2 (zeige TCF7L2 Antikörper) mediates canonic Wnt (zeige WNT2 Antikörper)/beta-catenin (zeige CTNNB1 Antikörper) signaling and c-Myc upregulation during abnormal cardiac remodeling in heart failure and suppression of Wnt (zeige WNT2 Antikörper)/beta-catenin (zeige CTNNB1 Antikörper) to c-Myc axis can be explored for preventing and treating heart failure.

Zebrafish V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Interaktionspartner

  1. Apoptosis was also observed with myca expression; introduction of homozygous tp53 (zeige TP53 Antikörper)(-/-) mutation into the myca transgenic fish reduced apoptosis and accelerated tumor progression.

  2. MYC down-regulation induces mitochondrial apoptosis in T lymphoblasts.

Human V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Interaktionspartner

  1. The MUC1 (zeige MUC1 Antikörper) oncoprotein was identified as the critical driver of (extracellular vesicle) EV-mediated myeloid-derived suppressor cells expansion in AML (zeige RUNX1 Antikörper). microRNA miR34a acts as the regulatory mechanism by which MUC1 (zeige MUC1 Antikörper) drives c-myc expression in AML (zeige RUNX1 Antikörper) cells and EVs.

  2. Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 (zeige BCL2 Antikörper) expression shows evidence of active B-cell receptor signaling

  3. Emetine induced cell death in primary refractory lymphoma cells with MYC rearrangement.

  4. The presence of MYC amplifications in two cases of cutaneous angiosarcoma secondary to chronic lymphedema of morbid obesity is described

  5. MYC-dependent attenuation of GCLC (zeige GCLC Antikörper) by miR (zeige MLXIP Antikörper)-18a contributes to GSH depletion in vivo, and low GSH corresponds with increased sensitivity to oxidative stress in tumors.

  6. Our data reveal the existence of a feedback loop between c-Myc and lncRNA-MIF (zeige AMH Antikörper), through which c-Myc protein stability is finely controlled. Additionally, we show that the lncRNA-MIF (zeige AMH Antikörper) inhibits aerobic glycolysis and tumorigenesis by suppressing c-Myc and miR (zeige MLXIP Antikörper)-586.

  7. DNA methylation (zeige HELLS Antikörper) levels at CpG sites in MYC may be associated specifically with the risk of aggressive prostate cancer.

  8. PSME3 (zeige PSME3 Antikörper) plays an oncogenic role in pancreatic cancer by inhibiting c-Myc degradation to promote glycolysis.

  9. ADA3 (zeige TADA3 Antikörper) overexpression enhances cell proliferation that is associated with increased expression of c-MYC. Expression patterns with respect to ADA3 (zeige TADA3 Antikörper)/c-MYC can divide patients into four significantly different subgroups, with c-MYC High and ADA3 (zeige TADA3 Antikörper) Low status independently predicting poor survival in patients.

  10. Data suggest that sulforaphane (SFN (zeige SFN Antikörper)) exerted anticancer functions through upregulation of microRNA miR (zeige MLXIP Antikörper)-214, which in turn targets the coding region of c-MYC and beta-catenin (zeige CTNNB1 Antikörper).

Rabbit V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Interaktionspartner

  1. report the isolation of complete coding regions of rabbit SOX2, KLF4, C-MYC and NANOG, which encode transcription factors that play crucial regulatory roles during early mammalian embryonic development

Cow (Bovine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Interaktionspartner

  1. Ouabain-induced proliferation might be attributed, at least in part, to decrease of intracellular free calcium and increase of c-myc mRNA expression, and that may be directly or indirectly involved in regulation of blood pressure.

C-MYC (MYC) Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene.

Alternative names and synonyms associated with C-MYC (MYC)

  • v-myc myelocytomatosis viral oncogene homolog (LOC100136746) Antikörper
  • myelocytomatosis oncogene (Myc) Antikörper
  • myelocytomatosis oncogene a (myca) Antikörper
  • v-myc avian myelocytomatosis viral oncogene homolog (MYC) Antikörper
  • v-myc myelocytomatosis viral oncogene homolog (MYC) Antikörper
  • v-myc myelocytomatosis viral oncogene homolog (avian) (MYC) Antikörper
  • AU016757 Antikörper
  • bHLHe39 Antikörper
  • C-MYC Antikörper
  • CMyc Antikörper
  • LOC100136746 Antikörper
  • mMyc Antikörper
  • MRTL Antikörper
  • MYC Antikörper
  • Myc2 Antikörper
  • MYCC Antikörper
  • Niard Antikörper
  • Nird Antikörper
  • RNCMYC Antikörper
  • zc-myc Antikörper

Bezeichner auf Proteinebene für MYC

v-myc myelocytomatosis viral oncogene homolog , Avian myelocytomatosis viral (v-myc) oncogene homolog , myc proto-oncogene protein , myelocytomatosis viral oncogene homolog , proto-oncogene c-Myc , transcription factor p64 , v-myc avian myelocytomatosis viral oncogene homolog , c-myc proto-oncogene , C-Myc1 , c-Myc-A , cellular myelocytomatosis oncogene , cmyca , transcriptional regulator Myc-A , avian myelocytomatosis viral oncogene homolog , class E basic helix-loop-helix protein 39 , myc-related translation/localization regulatory factor , avian myelocytomatosis viral (v-myc) oncogene homolog , c-Myc , Proto-oncogene c-Myc , Transcription factor p64 , Myc proto-oncogene protein

GENE ID SPEZIES
100136746 Oncorhynchus mykiss
24577 Rattus norvegicus
17869 Mus musculus
30686 Danio rerio
4609 Homo sapiens
420332 Gallus gallus
100327265 Oryctolagus cuniculus
403924 Canis lupus familiaris
448810 Sus scrofa
511077 Bos taurus
100379628 Felis catus
443447 Ovis aries
694626 Macaca mulatta
464393 Pan troglodytes
100407754 Callithrix jacchus
100972175 Pan paniscus
Ausgewählte Anbieter für anti-C-MYC (MYC) Antikörper
Haben Sie etwas anderes gesucht?